Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
Regor Therapeutics has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2021.
Regor Therapeutics's investors include Eli Lilly, Lilly Asia Ventures, Loyal Valley Capital, Vertex Ventures China, TF Capital.
Regor Therapeutics is headquartered in Boston, United States.
Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
Regor Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Regor Therapeutics — Funding & Investors." VCBacked, December 10, 2021, https://www.vcbacked.co/company/regor-therapeutics. Accessed September 13, 2026.
VCBacked. (2021). Regor Therapeutics — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/regor-therapeutics
{{cite web |title=Regor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/regor-therapeutics |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated